Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Mullen

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cytokines, Cellular & Molecular Therapy|June 13, 2000
Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study GroupE B Keeffe, G M Dusheiko, S P James, et al.
The Journal of Clinical Investigation|February 1, 1988
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiencyW A Gahl, I Bernardini, J D Finkelstein, et al.
The International Journal of Artificial Organs|August 21, 2001
A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathyL Kramer, A Gendo, C Madl, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Gastroenterology|November 1, 1988
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis BJ H Hoofnagle, M Peters, K D Mullen, et al.
American Journal of Human Genetics|January 1, 1987
Hepatic methionine adenosyltransferase deficiency in a 31-year-old manW A Gahl, J D Finkelstein, K D Mullen, et al.
Annals of Internal Medicine|May 1, 1986
Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapyA E Read, R H Wiesner, D R LaBrecque, et al.
Journal of Hepatology|February 24, 2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapyZ M Younossi, K D Mullen, W Zakko, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study GroupW M Lee, K R Reddy, M J Tong, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled studyA Sanyal, Z M Younossi, N M Bass, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cytokines, Cellular & Molecular Therapy|June 13, 2000
Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study GroupE B Keeffe, G M Dusheiko, S P James, et al.
The Journal of Clinical Investigation|February 1, 1988
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiencyW A Gahl, I Bernardini, J D Finkelstein, et al.
The International Journal of Artificial Organs|August 21, 2001
A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathyL Kramer, A Gendo, C Madl, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Gastroenterology|November 1, 1988
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis BJ H Hoofnagle, M Peters, K D Mullen, et al.
American Journal of Human Genetics|January 1, 1987
Hepatic methionine adenosyltransferase deficiency in a 31-year-old manW A Gahl, J D Finkelstein, K D Mullen, et al.
Annals of Internal Medicine|May 1, 1986
Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapyA E Read, R H Wiesner, D R LaBrecque, et al.
Journal of Hepatology|February 24, 2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapyZ M Younossi, K D Mullen, W Zakko, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study GroupW M Lee, K R Reddy, M J Tong, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled studyA Sanyal, Z M Younossi, N M Bass, et al.
Pageof 8